Clinical Trial Update: W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne [Phase 1]

View source ↗

Summary

Phase 1, randomized, open-label study assessing the bioavailability of three clindamycin/benzoyl peroxide gel formulations for acne vulgaris; study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Clindamycin 1% - Benzoyl Peroxide 3% Gel (clindamycin; benzoyl peroxide)
• Clindamycin 1% - Benzoyl Peroxide 5% Gel (clindamycin; benzoyl peroxide)
• Clindamycin 1% - Benzoyl Peroxide 5% Once Daily Gel (clindamycin; benzoyl peroxide)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED